Asset Allocation

As of March 31, 2026.
Type % Net
Cash 1.39%
Stock 96.89%
Bond 1.72%
Convertible 0.00%
Preferred 0.00%
Other 0.00%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 7.58%
Mid 34.27%
Small 58.16%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.01%    % Emerging Markets: 0.77%    % Unidentified Markets: 1.22%

Americas 95.44%
94.03%
Canada 1.83%
United States 92.20%
1.41%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 3.34%
United Kingdom 1.63%
1.21%
Ireland 0.26%
Netherlands 0.46%
Switzerland 0.49%
0.00%
0.50%
Israel 0.50%
Greater Asia 0.00%
Japan 0.00%
0.00%
0.00%
0.00%
Unidentified Region 1.22%

Stock Sector Exposure

Cyclical
32.88%
Materials
5.05%
Consumer Discretionary
11.40%
Financials
13.72%
Real Estate
2.71%
Sensitive
42.48%
Communication Services
3.10%
Energy
3.75%
Industrials
21.66%
Information Technology
13.96%
Defensive
21.59%
Consumer Staples
8.70%
Health Care
11.21%
Utilities
1.68%
Not Classified
3.06%
Non Classified Equity
0.00%
Not Classified - Non Equity
3.05%
As of March 31, 2026
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available